Safety and efficacy of Zilretta administered to patients with Greater Trochanteric Bursitis

Pain on the outside of the hip is a common complaint that often stems from a small, fluid-filled sac called a bursa. Think of this sac as a tiny cushion that sits between the bone and the tendons, allowing them to glide smoothly over one another without friction. When this cushion becomes inflamed, usually due to repetitive movement or minor injury, it causes a condition known as greater trochanteric bursitis. For many people, this results in a persistent, aching pain that makes walking, climbing stairs, or even lying on that side difficult. While doctors have long used standard steroid injections to calm this inflammation, these treatments often wear off quickly, requiring repeated visits and injections that can sometimes cause thinning of the skin or other side effects.

Researchers have been exploring whether a newer, longer-lasting version of this steroid medication could provide relief for a longer period without the downsides. This specific medication, known as Zilretta, is already approved for treating pain in the knee, where it slowly releases its active ingredient over several months. However, until recently, no one had tested whether this extended-release formula would work effectively when injected into the hip bursa. A team of medical professionals at The University of Texas Health Science Center at Houston set out to answer this question, aiming to see if this approach could offer a safer, more durable solution for patients suffering from chronic hip pain.

The study involved twenty-two patients who had been diagnosed with chronic bursitis in the hip. These individuals were not new to the problem; they had been dealing with pain caused by overuse or minor trauma for some time. Before receiving any treatment, each patient rated their pain on a standard scale and shared their overall impression of their condition. The medical team then used ultrasound imaging to guide a needle precisely into the inflamed bursa. Instead of a standard dose, they injected five milliliters of the extended-release steroid, followed by up to three milliliters of a local anesthetic to numb the area immediately. Two of the participants received this treatment on both hips, bringing the total number of injections to twenty-four.

Following the procedure, the researchers kept a close watch on the patients for twelve weeks. They checked in at regular intervals, asking the same questions about pain levels and how much the treatment had helped. The results showed a clear and rapid improvement. Within just one week of the injection, the average pain score dropped significantly, and patients reported feeling much better overall. While the most dramatic changes happened early on, the data suggested that this relief did not simply vanish. Over the course of the three-month study, the patients maintained a trend of reduced pain and increased satisfaction, indicating that the medication continued to work as it slowly released into the surrounding tissue.

Safety was a primary focus of the investigation, and the findings were reassuring. None of the twenty-two patients experienced any serious adverse events during the twelve-week period. There were a few minor reports, such as temporary pain at the injection site, a headache, or a small lump where the needle entered, but these were mild and did not escalate into serious complications. Crucially, the study found no signs of the skin thinning or discoloration that can sometimes occur with traditional steroid injections, suggesting that the extended-release formula might be gentler on the surrounding tissue.

The researchers concluded that injecting this extended-release steroid into the hip bursa is a safe and effective way to manage pain. The treatment provided significant relief that lasted for at least three months, offering a promising alternative for patients who have not found lasting help from other methods. While the study was small and focused on a short timeframe, the results point toward a viable new option for treating this common source of hip pain. The authors noted that future research should compare this method directly with standard treatments and explore whether repeated injections could offer even longer-term benefits, but for now, the data suggests that this approach can help people move more comfortably with fewer side effects.